ABIVAX Société Anonyme (LON: 0RA9)
London
· Delayed Price · Currency is GBP · Price in EUR
6.13
-0.03 (-0.49%)
Jan 23, 2025, 1:41 PM BST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 61 employees as of December 30, 2023. The number of employees increased by 37 or 154.17% compared to the previous year.
Employees
61
Change (1Y)
37
Growth (1Y)
154.17%
Revenue / Employee
123.49K GBP
Profits / Employee
-2.43M GBP
Market Cap
332.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
ABIVAX Société Anonyme News
- 13 days ago - Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment - GlobeNewsWire
- 4 weeks ago - Abivax Announces a Change to the Composition of its Board of Directors - GlobeNewsWire
- 2 months ago - Abivax Establishes an At-the-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 2 months ago - Abivax presents third quarter 2024 key financial information - GlobeNewsWire
- 2 months ago - Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax - GlobeNewsWire
- 3 months ago - Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewsWire
- 3 months ago - Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's Disease - GlobeNewsWire
- 4 months ago - Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance - GlobeNewsWire